Skip to main content
SpringerLink
Log in

Primary cutaneous melanoma: surgical management and other treatment options

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

The incidence of primary cutaneous melanoma continues to increase and is a growing public health problem. By virtue of its metastatic potential, melanoma accounts for most of the deaths from cutaneous malignancies. Management of cutaneous melanoma has undergone a paradigm shift in recent years. Clinical studies have furthered our understanding of the biology of this disease and have changed the standards of care. Specifically, sentinel node biopsy and interferon as the first effective postsurgical therapy have had a significant impact on the treatment of patients with melanoma. Surgery remains the primary treatment modality for cutaneous melanoma. An adequate excision of the primary lesion accomplishes durable local control and is curative for patients without micrometastatic disease. Although the extent of surgical resection has decreased in recent years, the standard treatment for primary cutaneous melanoma remains wide surgical excision with histologically negative margins. The extent of excision is based on the theory that the incidence and radial extent of local recurrences can be predicted by specific primary tumor histopathologic characteristics. Tumor thickness and ulceration are the most important histologic features associated with prognosis and are the basis for the current recommendations for surgical treatment of the primary tumor. The extent of surgical therapy for primary melanoma is an area of ongoing debate. No clinical trial has shown a survival disadvantage for narrow versus wide excision regimens for melanoma of any thickness. Ongoing clinical trials will determine the relationship between the extent of surgical therapy for the primary tumor and the outcomes of recurrence and survival in patients with melanoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Howe HL, Wingo PA, Thun MJ, et al.: Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001, 93:824–842.

    Article  PubMed  CAS  Google Scholar 

  2. Geller AC, Miller DR, Annas GD, et al.: Melanoma incidence and mortality among US whites, 1969–1999. JAMA 2002, 288:1719–1720. This paper shows the recent trends in melanoma incidence and mortality among whites in the United States.

    Article  PubMed  Google Scholar 

  3. Rigel DS, Friedman RJ, Kopf AW: The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996, 34:839–847.

    Article  PubMed  CAS  Google Scholar 

  4. Balch CM, Buzaid AC, Soong SJ, et al.: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001, 19:3635–3648. This article illustrates the most recent AJCC melanoma staging system and describes the most pertinent prognostic indicators in melanoma.

    PubMed  CAS  Google Scholar 

  5. Handley WS: The pathology of melanotic growths in relation to their operative treatment. Lancet 1907, 1:927.

    Google Scholar 

  6. Breslow A, Macht SD: Optimal size of resection margin for thin cutaneous melanoma. Surg Gynecol Obstet 1977, 145:691–692.

    PubMed  CAS  Google Scholar 

  7. Elder DE, Guerry D, Heiberger RM, et al.: Optimal resection margins for cutaneous malignant melanoma. Plast Reconstr Surg 1983, 71:66–72.

    PubMed  CAS  Google Scholar 

  8. Goldman LI, Byrd R: Narrowing resection margins for patients with low-risk melanoma. Am J Surg 1988, 155:242–44.

    PubMed  CAS  Google Scholar 

  9. Day CL, Mihm MC, Sober AJ, et al.: Narrower margins for clinical stage I malignant melanoma. N Eng J Med 1982, 306:479–482.

    Article  Google Scholar 

  10. Soong SJ, Weiss HL: Predicting outcome in patients with localized melanoma. In Cutaneous Melanoma. Edited by Balch CM, Houghton AN, Sober AJ, Soong SJ. St. Louis: Quality Medical Publishing; 1998:51–61.

    Google Scholar 

  11. Balch CM, Buzaid AC, Atkins MB, et al.: A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 2000, 88:1484–1491.

    Article  PubMed  CAS  Google Scholar 

  12. Gershenwald JE, Thompson W, Mansfield PF, et al.: Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999, 17:976–983. This article illustrates the primary prognostic importance of sentinel node status in patients with stage I and II melanoma.

    PubMed  CAS  Google Scholar 

  13. Wagner JD, Gordon MS, Chuang TY, et al.: Current therapy of cutaneous melanoma. Plast Reconstr Surg 2000, 105:1774–1799.

    Article  PubMed  CAS  Google Scholar 

  14. NIH consensus conference. Diagnosis and treatment of early melanoma.JAMA 1992, 268:1314–1319. This article discusses the consensus of opinions for treatment of patients with low-risk primary melanomas.

  15. Veronesi U, Cascinelli N, Adamus J, et al.: Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3cm. N Engl J Med 1988, 318:1159–1162. The article provides the primary scientific foundation on which treatment of melanomas up to 2 mm deep is based.

    Article  PubMed  CAS  Google Scholar 

  16. Balch CM, Urist MM, Karakousis CP, et al.: Efficacy of 2-cm surgical margins for intermediate thickness melanomas (1 to 4 mm): results of a multi-institutional randomized surgical trial. Ann Surg 1993, 218:262–69. This article provides the primary scientific basis for the treatment of intermediate-thickness melanoma 1 to 4 mm deep.

    Article  PubMed  CAS  Google Scholar 

  17. Ringborg U, Andersson R, Eldh J, et al.: Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish melanoma study group. Cancer 1996, 77:1809–1814.

    Article  PubMed  CAS  Google Scholar 

  18. Ross MI, Balch CM: Surgical treatment of primary melanoma. In Cutaneous Melanoma. Edited by Balch CM, Houghton AN, Sober AJ, Soong SJ. St. Louis: Quality Medical Publishing; 1998:141–153.

    Google Scholar 

  19. Thomas JM, Newton-Bishop JA, Timmons M, et al.: Surgical margin excision width in high risk (minimum depth 2 mm) cutaneous malignant melanoma: a randomized trial of 1 cm versus 3 cm margins in 900 patients [abstract]. Prog Proc Am Soc Clin Oncol 2002, 21:340. This abstract describes the largest melanoma excision trial that is the only trial to include melanomas greater than 4 mm deep. It is also the only trial to show a disadvantage for narrower margins of excision.

    Google Scholar 

  20. Gershenwald JE, Colome ME, Lee JE, et al.: Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998, 16:2253–2260.

    PubMed  CAS  Google Scholar 

  21. Clary BM, Mann B, Brady MS, et al.: Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection. Ann Surg Oncol 2001, 8:328–337.

    Article  PubMed  CAS  Google Scholar 

  22. Cooper PH, Mills SE, Allen MS Jr: Malignant melanoma of the anus. Report of 12 patients and analysis of 255 additional cases. Dis Colon Rectum 1982, 25:693–703.

    Article  PubMed  CAS  Google Scholar 

  23. Brady MS, Kavolius JP, Quan SH: Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum 1995, 38:146–151.

    Article  PubMed  CAS  Google Scholar 

  24. Ballo MT, Gershenwald JE, Gunar K, et al.: Sphinctersparing local excision and adjuvant radiation for analrectal melanoma. J Clin Oncol 2002, 20:4555–4558.

    Article  PubMed  Google Scholar 

  25. Cascinelli N, Belli F, Santinami M, et al.: Sentinel lymph node biopsy in cutaneous melanoma: the WHO melanoma program experience. Ann Surg Oncol 2000, 7:469–474. This article illustrates the use of SNB for staging patients with early stage melanoma.

    Article  PubMed  CAS  Google Scholar 

  26. Wagner JD, Gordon MS, Chuang TY, et al.: Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 2000, 89:453–462.

    Article  PubMed  CAS  Google Scholar 

  27. Zitelli JA, Brown CD, Hanusa BH: Surgical margins for excision of primary cutaneous melanoma. J Am Acad Dermatol 1997, 37:422–429. This article shows the extent of surgical margins of excision necessary to achieve histologically clear margins in patients with melanoma.

    Article  PubMed  CAS  Google Scholar 

  28. Zitelli JA, Brown C, Hanusa BH: Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol 1997, 37:236–245. This article describes a nonrandomized trial showing the possible applicability of MMS for patients with melanoma.

    Article  PubMed  CAS  Google Scholar 

  29. Albertini JG, Elston DM, Libow LF, et al.: Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Dermatol Surg 2002, 28:656–663.

    Article  PubMed  Google Scholar 

  30. Anderson TD, Weber RS, Dupont G, et al.: Desmoplastic neurotropic melanoma of the head and neck: the role of radiation therapy. Head Neck 2002, 24:1068–1071.

    Article  PubMed  Google Scholar 

  31. Demierre M, Nathanson L: Chemoprevention of melanoma: an unexplored strategy. J Clin Oncol 2003, 21:158–165.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Plastic and Reconstructive Surgery, Indiana University School of Medicine, 535 Barnhill Drive, RT 471, 46202, Indianapolis, IN, USA

    Jeffrey D. Wagner MD

Authors
  1. Jeffrey D. Wagner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Debra Bergman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wagner, J.D., Bergman, D. Primary cutaneous melanoma: surgical management and other treatment options. Curr. Treat. Options in Oncol. 4, 177–185 (2003). https://doi.org/10.1007/s11864-003-0019-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-003-0019-6

Keywords

Search

Navigation